Comparison of effects of low-level laser therapy and extracorporeal shock wave therapy in plantar fasciitis treatment: A randomized, prospective, single-blind clinical study.
Autor: | Yinilmez Sanmak ÖD; Department of Physical Medicine and Rehabilitation, Mardin Derik State Hospital, Mardin, Turkey., Geler Külcü D; Department of Physical Medicine and Rehabilitation, Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey., Mesci N; Department of Physical Medicine and Rehabilitation, Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey., Altunok EÇ; Department of Biostatistics, Yeditepe University Faculty of Medicine, İstanbul, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | Turkish journal of physical medicine and rehabilitation [Turk J Phys Med Rehabil] 2018 Oct 27; Vol. 65 (2), pp. 184-190. Date of Electronic Publication: 2018 Oct 27 (Print Publication: 2019). |
DOI: | 10.5606/tftrd.2019.3528 |
Abstrakt: | Objectives: The aim of this study is to compare the efficacy of extracorporeal shock wave therapy (ESWT) and low-level laser therapy (LLLT) in terms of fascia thickness, heel pain, and foot functions in patients with plantar fasciitis (PF). Patients and Methods: Between April 2015 and October 2015, a total of 34 patients (5 males, 29 females; mean age 51.5±10.8 years; range, 18 to 65 years) with PF were randomized into two treatment groups to receive either ESWT or LLLT using closed envelope method. The patients were evaluated before and after treatment and one month after treatment using the visual analog scale (VAS)-pain, Foot Function Index (FFI), and plantar fascia thickness measured by ultrasonography. Results: A significant improvement in the VAS-pain and FFI scores and plantar fascia thickness was observed in both groups after treatment and one month after treatment, compared to pre-treatment values (p<0.05). Changes over time in these outcome parameters were not different between study groups (p>0.05). Conclusion: Our study results suggest that both ESWT and LLLT seem to be effective on pain, foot functions, and fascia thickness in the treatment of PF.Presented at the 26th National Congress of Physical Medicine and Rehabilitation, April 25-29, 2017 Antalya, Turkey. Competing Interests: Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article. |
Databáze: | MEDLINE |
Externí odkaz: |